Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-04-23CASI3
Nano CapBiotechnology
2026-04-23CANF3SEC Filing Summary for Can-Fite BioPharma Ltd. - Officer/Director ChangeMEDIUM
This filing details a Form 3, Initial Statement of Beneficial Ownership, for Ilan Tamir, a director at Can-Fite BioPharma Ltd. The report, dated March 18, 2026, indicates that Tamir holds options to purchase 16,000 ordinary shares. These options are not currently vested and will vest in sixteen equal quarterly installm...
Nano CapBiotechnology
2026-04-23ADTX3Ownership Filing for HRT FINANCIAL LPMEDIUM
HRT FINANCIAL LP, a 10% owner of Aditxt, Inc. (ADTX), reported a change in their holdings. Following a recent transaction, HRT FINANCIAL LP now directly owns 133,574 shares of Aditxt, Inc. Class A Shares. The owner, HRT FINANCIAL LP, is based in New York, NY, and the filing was signed by Adam Nunes on April 23, 2026, w...
Nano CapBiotechnology